Clinical Trials Fund
CIHR is committed to fully supporting the clinical trials pipeline from discovery to implementation. Ultimately, an early priority of the Clinical Trials Fund (CTF) is to develop a deep national dialogue that will lead to a robust, pan-Canadian clinical trials strategy. In the first allocation of funds, the CTF will reinforce Canada’s clinical trials ecosystem by investing in three funding streams:
Pan-Canadian Clinical Trials Consortium
Clinical Trials Training Platforms
The Clinical Trials Fund also supports CIHR’s Strategic Plan 2021–2031 and priorities, in particular, integrating evidence in health decisions, strengthening Canadian health research capacity, and pursuing health equity through research.
- Date modified: